Voltage-Gated Potassium Channel Kv1.3 as a Target in Therapy of Cancer.

Kv1.3 channel Kv1.3 channel inhibitors apoptosis cancer proliferation

Journal

Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867

Informations de publication

Date de publication:
2019
Historique:
received: 07 05 2019
accepted: 06 09 2019
entrez: 16 10 2019
pubmed: 16 10 2019
medline: 16 10 2019
Statut: epublish

Résumé

Voltage-gated potassium channel Kv1.3 is an integral membrane protein, which is selectively permeable for potassium ions and is activated upon a change of membrane potential. Channel activation enables transportation of potassium ions down their electrochemical gradient. Kv1.3 channel is expressed in many cell types, both normal and cancer. Activity of the channel plays an important role in cell proliferation and apoptosis. Inhibition of Kv1.3 channel may be beneficial in therapy of several diseases including some cancer disorders. This review focuses on Kv1.3 channel as a new potentially attractive molecular target in cancer therapy. In the first part, changes in the channel expression in selected cancer disorders are described. Then, the role of the channel activity in cancer cell proliferation and apoptosis is presented. Finally, it is shown that some low molecular weight organic inhibitors of the channel including selected biologically active plant-derived polycyclic compounds may selectively induce apoptosis of Kv1.3-expressing cancer cells while sparing normal cells and healthy organs. These compounds may be promising candidates for putative application in therapy of some cancer disorders, such as melanoma, pancreatic ductal adenocarcinoma (PDAC), or B-type chronic lymphocytic leukemia (B-CLL).

Identifiants

pubmed: 31612103
doi: 10.3389/fonc.2019.00933
pmc: PMC6769076
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

933

Informations de copyright

Copyright © 2019 Teisseyre, Palko-Labuz, Sroda-Pomianek and Michalak.

Références

Cell Physiol Biochem. 2009;24(1-2):25-32
pubmed: 19590190
J Membr Biol. 2015 Aug;248(4):705-11
pubmed: 25688010
J Biol Chem. 2016 Feb 12;291(7):3569-80
pubmed: 26655221
PLoS One. 2008;3(12):e4009
pubmed: 19104661
Biomed Pharmacother. 2019 Jan;109:1511-1522
pubmed: 30551403
Biochim Biophys Acta. 2010 Jun-Jul;1797(6-7):1251-9
pubmed: 20114030
Front Oncol. 2018 Apr 23;8:122
pubmed: 29740538
Proc Natl Acad Sci U S A. 2000 Sep 26;97(20):10872-7
pubmed: 10984511
Sci Rep. 2015 Nov 30;5:17381
pubmed: 26616555
J Cell Physiol. 2017 Dec;232(12):3786-3797
pubmed: 28213961
Front Physiol. 2013 Oct 10;4:283
pubmed: 24133455
Discov Med. 2017 Mar;23(126):155-162
pubmed: 28472608
Cancer Lett. 2004 Nov 25;215(2):159-66
pubmed: 15488634
Curr Pharm Des. 2014;20(2):189-200
pubmed: 23701546
Int J Mol Sci. 2018 Jul 15;19(7):null
pubmed: 30011966
Pflugers Arch. 2003 Aug;446(5):559-71
pubmed: 12838421
Immunol Rev. 2009 Sep;231(1):59-87
pubmed: 19754890
Cell Mol Biol Lett. 2012 Dec;17(4):559-70
pubmed: 22933043
Oncol Lett. 2012 Aug;4(2):227-230
pubmed: 22844358
J Membr Biol. 2018 Dec;251(5-6):695-704
pubmed: 30187077
J Membr Biol. 2005 May;205(2):71-9
pubmed: 16283587
J Membr Biol. 2006;214(2):99-102
pubmed: 17546508
Life Sci. 2005 Aug 26;77(15):1879-91
pubmed: 15916776
J Steroid Biochem Mol Biol. 2009 Feb;113(3-5):163-70
pubmed: 19103290
Arterioscler Thromb Vasc Biol. 2012 May;32(5):1299-307
pubmed: 22383699
Front Oncol. 2017 Sep 29;7:239
pubmed: 29034212
FEBS J. 2014 Aug;281(15):3433-45
pubmed: 24924920
Expert Opin Ther Targets. 2016;20(5):577-91
pubmed: 26634786
Pharmacol Rev. 2012 Jan;64(1):102-46
pubmed: 22106090
Phytomedicine. 2006 Nov;13(9-10):732-4
pubmed: 16678392
Curr Med Chem. 2012;19(5):661-74
pubmed: 22204339
Phytochemistry. 2004 May;65(10):1317-30
pubmed: 15231405
Nat Rev Cancer. 2014 Nov;14(11):709-21
pubmed: 25342630
J Biochem Mol Biol. 2006 Jul 31;39(4):448-51
pubmed: 16889690
Leukemia. 2013 Aug;27(8):1782-5
pubmed: 23426166
Food Chem Toxicol. 1999 Apr;37(4):271-85
pubmed: 10418944
Annu Rev Immunol. 2015;33:291-353
pubmed: 25861976
Biochem Pharmacol. 2003 Feb 15;65(4):551-61
pubmed: 12566082
J Physiol. 1985 Jan;358:197-237
pubmed: 2580081
J Biol Chem. 2015 May 15;290(20):12547-57
pubmed: 25829491
Pancreas. 2009 Aug;38(6):649-54
pubmed: 19465885
BMB Rep. 2009 Aug 31;42(8):535-9
pubmed: 19712592
Cell Physiol Biochem. 2015;37(3):965-78
pubmed: 26393354
Curr Opin Chem Biol. 2017 Jun;38:97-107
pubmed: 28412597
Anticancer Res. 2007 Nov-Dec;27(6B):4127-33
pubmed: 18225583
Wien Med Wochenschr. 2015 Jun;165(11-12):258-61
pubmed: 25925225
Curr Cancer Drug Targets. 2009 Dec;9(8):904-14
pubmed: 20025600
Biochem J. 2009 Jan 1;417(1):1-13
pubmed: 19061483
Neurosignals. 2017;25(1):26-38
pubmed: 28869943
Curr Pharm Des. 2006;12(18):2199-220
pubmed: 16787250
Am J Physiol Cell Physiol. 2018 Jan 1;314(1):C27-C42
pubmed: 28931540
Prostate. 2001 Mar 1;46(4):262-74
pubmed: 11241548
Expert Opin Ther Targets. 2018 Feb;22(2):101-105
pubmed: 29258373
Nature. 1984 Feb 2-8;307(5950):468-71
pubmed: 6320008
Pharmacol Rep. 2014 Aug;66(4):712-7
pubmed: 24948077
Proc Natl Acad Sci U S A. 2008 Sep 30;105(39):14861-6
pubmed: 18818304
Nutrition. 2016 Nov-Dec;32(11-12):1171-8
pubmed: 27238957
Adv Clin Exp Med. 2015 May-Jun;24(3):517-24
pubmed: 26467143
J Membr Biol. 2006;214(3):123-9
pubmed: 17557164
J Physiol Pharmacol. 2009 Mar;60(1):69-76
pubmed: 19439809
Cancer Cell. 2017 Apr 10;31(4):516-531.e10
pubmed: 28399409
J Biol Chem. 2003 Aug 29;278(35):33319-26
pubmed: 12807917
Cancer Detect Prev. 2006;30(4):375-85
pubmed: 16971052
Front Physiol. 2018 May 09;9:499
pubmed: 29867547
J Gen Physiol. 1992 Jan;99(1):63-84
pubmed: 1371308
J Chromatogr A. 1999 Feb 5;832(1-2):97-107
pubmed: 10070768
J Biol Chem. 2005 Apr 1;280(13):12790-8
pubmed: 15632141
Phytother Res. 2008 Feb;22(2):197-203
pubmed: 17726738
Oncotarget. 2017 Jun 13;8(24):38276-38293
pubmed: 27542263
Cell Physiol Biochem. 2014;34(4):1359-72
pubmed: 25301362
Mol Cells. 2007 Aug 31;24(1):95-104
pubmed: 17846503
EMBO Mol Med. 2012 Jul;4(7):577-93
pubmed: 22496117
Nat Rev Drug Discov. 2009 Dec;8(12):982-1001
pubmed: 19949402
Pharmacol Rev. 2005 Dec;57(4):473-508
pubmed: 16382104

Auteurs

Andrzej Teisseyre (A)

Department of Biophysics, Wroclaw Medical University, Wrocław, Poland.

Anna Palko-Labuz (A)

Department of Biophysics, Wroclaw Medical University, Wrocław, Poland.

Kamila Sroda-Pomianek (K)

Department of Biophysics, Wroclaw Medical University, Wrocław, Poland.

Krystyna Michalak (K)

Department of Biophysics, Wroclaw Medical University, Wrocław, Poland.

Classifications MeSH